Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
55 hedge funds and large institutions have $35.3M invested in Ampio Pharmaceuticals Inc. in 2017 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 5 closing their positions.
733% more capital invested
Capital invested by funds: $4.24M → $35.3M (+$31.1M)
200% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 5
40% more call options, than puts
Call options by funds: $2.31M | Put options by funds: $1.64M
30% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 10
22% more funds holding
Funds holding: 45 → 55 (+10)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.58M |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$387K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$386K |
| 4 |
VF
Virtu Financial
New York
|
+$128K |
| 5 |
TW
Transform Wealth
Greenwood Village,
Colorado
|
+$102K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$266K |
| 2 |
NFG
Noven Financial Group
Denver,
Colorado
|
-$137K |
| 3 |
Wolverine Trading
Chicago,
Illinois
|
-$18.8K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$12.2K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$10.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GEA
51
Glen Eagle Advisors
Kingston,
New Jersey
| $4.07K | +$1.41K | +3 | New |
|
|
MAM
52
Meeder Asset Management
Dublin,
Ohio
| $2K | -$4.23K | -9 | -82% |
|
53
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | +$470 | +1 | +100% |
|
|
WWMSC
54
Wagner Wealth Management (South Carolina)
Greenville,
South Carolina
| $1K | +$940 | +2 | New |
|
55
BNP Paribas Financial Markets
Paris,
France
| $102 | – | – | – |
|
|
56
Wolverine Trading
Chicago,
Illinois
| – | -$18.8K | -40 | Closed |
|
|
CP
57
Corbenic Partners
Bethlehem,
Pennsylvania
| – | -$2K | -13 | Closed |
|
58
Simplex Trading
Chicago,
Illinois
| – | -$5.17K | -11 | Closed |
|
59
JP Morgan Chase
New York
| – | -$1K | -6 | Closed |
|
60
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$1K | -2 | Closed |
|
AMPE Hedge Fund Activity: Q4 2017 in Review
55 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q4 2017, worth a combined $35.3M — up 733% from $4.24M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new AMPE positions and 5 closed out — a net gain of 10 holders — while 13 added to existing stakes and 10 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.58M. The largest seller was Millennium Management, cutting an estimated $266K.
- 55 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q4 2017, up from 45 in Q3 2017.
- Funds reported $35.3M of Ampio Pharmaceuticals Inc. stock for Q4 2017, up 733% quarter-over-quarter.
- 15 funds opened new Ampio Pharmaceuticals Inc. positions in Q4 2017 and 5 closed out, a net change of +10 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q4 2017 was Vanguard Group, an estimated $1.58M added.
- The largest Ampio Pharmaceuticals Inc. seller in Q4 2017 was Millennium Management, an estimated $266K sold.
Based on aggregated 13F filings for Q4 2017.